Abstract:Background: Conventional approaches to drug discovery are often characterized by lengthy and costly processes. To expedite the discovery of new drugs, the integration of artificial intelligence (AI) in predicting drug-target binding affinity (DTA) has emerged as a crucial approach. Despite the proliferation of deep learning methods for DTA prediction, many of these methods primarily concentrate on the amino acid sequence of proteins. Yet, the interactions between drug compounds and targets occur within distinct segments within the protein structures, whereas the primary sequence primarily captures global protein features. Consequently, it falls short of fully elucidating the intricate relationship between drugs and their respective targets. Objective: This study aims to employ advanced deep-learning techniques to forecast DTA while incorporating information about the secondary structure of proteins. Methods: In our research, both the primary sequence of protein and the secondary structure of protein were leveraged for protein representation. While the primary sequence played the role of the overarching feature, the secondary structure was employed as the localized feature. Convolutional neural networks and graph neural networks were utilized to independently model the intricate features of target proteins and drug compounds. This approach enhanced our ability to capture drugtarget interactions more effectively Results: We have introduced a novel method for predicting DTA. In comparison to DeepDTA, our approach demonstrates significant enhancements, achieving a 3.9% increase in the Concordance Index (CI) and a remarkable 34% reduction in Mean Squared Error (MSE) when evaluated on the KIBA dataset. Conclusion: In conclusion, our results unequivocally demonstrate that augmenting DTA prediction with the inclusion of the protein's secondary structure as a localized feature yields significantly improved accuracy compared to relying solely on the primary structure.

Deep learning for advancing peptide drug development: Tools and methods in structure prediction and design

Deep Learning-Based Bioactive Therapeutic Peptide Generation and Screening

Implementation of Deep Learning in Drug Design

Structure-based protein design with deep learning

Deep Learning in Structure-Based Drug Design

Deep Learning in Protein Structural Modeling and Design

Peptide-based drug discovery through artificial intelligence: towards an autonomous design of therapeutic peptides

Discovery of Highly Bioactive Peptides through Hierarchical Structural Information and Molecular Dynamics Simulations

Structure-based drug discovery with deep learning

Leveraging Machine Learning Models for Peptide-Protein Interaction Prediction

Recent Progress in Machine Learning-based Prediction of Peptide Activity for Drug Discovery.

Deep generative models for peptide design

Recent Advances and Computational Approaches in Peptide Drug Discovery

Computational Peptidology: A New and Promising Approach to Therapeutic Peptide Design

PepGB: Facilitating peptide drug discovery via graph neural networks

Enhancing Drug-Target Binding Affinity Prediction through Deep Learning and Protein Secondary Structure Integration

Structure-based, deep-learning models for protein-ligand binding affinity prediction

A new age in protein design empowered by deep learning

A compact review of progress and prospects of deep learning in drug discovery

Application advances of deep learning methods for de novo drug design and molecular dynamics simulation

The role and future prospects of artificial intelligence algorithms in peptide drug development